DE69520882D1 - Arzneizubereitung enthaltend amoxycillin und kaliumclavunalat - Google Patents

Arzneizubereitung enthaltend amoxycillin und kaliumclavunalat

Info

Publication number
DE69520882D1
DE69520882D1 DE69520882T DE69520882T DE69520882D1 DE 69520882 D1 DE69520882 D1 DE 69520882D1 DE 69520882 T DE69520882 T DE 69520882T DE 69520882 T DE69520882 T DE 69520882T DE 69520882 D1 DE69520882 D1 DE 69520882D1
Authority
DE
Germany
Prior art keywords
clavunalate
potassium
preparation containing
medicinal preparation
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69520882T
Other languages
English (en)
Other versions
DE69520882T2 (de
Inventor
Ernest L G Rivett
Francis W Grimmett
Michael W Hartnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of DE69520882D1 publication Critical patent/DE69520882D1/de
Application granted granted Critical
Publication of DE69520882T2 publication Critical patent/DE69520882T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69520882T 1994-08-17 1995-08-08 Arzneizubereitung enthaltend amoxycillin und kaliumclavunalat Expired - Fee Related DE69520882T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9416600A GB9416600D0 (en) 1994-08-17 1994-08-17 Pharmaceutical formulation
PCT/EP1995/003151 WO1996004908A1 (en) 1994-08-17 1995-08-08 Pharmaceutical formulation containing amoxycillin and potassium clavulanate

Publications (2)

Publication Number Publication Date
DE69520882D1 true DE69520882D1 (de) 2001-06-13
DE69520882T2 DE69520882T2 (de) 2002-01-10

Family

ID=10759965

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69520882T Expired - Fee Related DE69520882T2 (de) 1994-08-17 1995-08-08 Arzneizubereitung enthaltend amoxycillin und kaliumclavunalat

Country Status (7)

Country Link
US (2) US5910322A (de)
EP (1) EP0776206B1 (de)
JP (1) JPH10504818A (de)
AT (1) ATE200981T1 (de)
DE (1) DE69520882T2 (de)
GB (1) GB9416600D0 (de)
WO (1) WO1996004908A1 (de)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
BR9610396A (pt) 1995-09-07 1999-07-06 Smithkline Beecham Corp Formulação farmacêutica
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407214B (de) * 1996-03-13 2001-01-25 Biochemie Gmbh Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
US7179486B1 (en) * 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
KR100502478B1 (ko) * 1997-06-13 2005-12-02 동아제약주식회사 클라불란산과베타락탐계항생물질을포함하는세균감염증치료제용약학적조성물
AUPP437698A0 (en) 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
GB2365337A (en) * 1999-04-13 2002-02-20 Beecham Pharma Amoxycillin and potassium clavulanate high dosage regimen
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
ATE242629T1 (de) * 1999-04-13 2003-06-15 Beecham Pharm Pte Ltd Neue behandlungsmethode unter verwendung einer hochdosierten form von amoxycillin und kaliumclavulanat
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US6669948B2 (en) 2000-02-24 2003-12-30 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6663890B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Metronidazole antibiotic product, use and formulation thereof
US6667057B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Levofloxacin antibiotic product, use and formulation thereof
US6638532B2 (en) 2000-02-24 2003-10-28 Advancis Pharmaceutical Corp. Tetracycline—doxycycline antibiotic composition
US6632453B2 (en) 2000-02-24 2003-10-14 Advancis Pharmaceutical Corp. Ciprofoxacin-metronidazole antibiotic composition
US6610328B2 (en) 2000-02-24 2003-08-26 Advancis Pharmaceutical Corp. Amoxicillin-clarithromycin antibiotic composition
US6667042B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Fluroquinilone antibiotic product, use and formulation thereof
US6663891B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Erythromyacin antibiotic product, use and formulation thereof
US6627222B2 (en) 2000-02-24 2003-09-30 Advancis Pharmaceutical Corp. Amoxicillin-dicloxacillin antibiotic composition
JP2003523372A (ja) 2000-02-24 2003-08-05 アドバンシス ファーマシューティカル コーポレイション 抗生物質及び抗真菌剤組成物
US6623758B2 (en) 2000-02-24 2003-09-23 Advancis Pharmaceutical Corp. Cephalosporin-metronidazole antibiotic composition
US6730320B2 (en) 2000-02-24 2004-05-04 Advancis Pharmaceutical Corp. Tetracycline antibiotic product, use and formulation thereof
JP2003531115A (ja) * 2000-02-24 2003-10-21 アドバンシス ファーマシューティカル コーポレイション インヒビターを有する抗生物質組成物
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US7025989B2 (en) * 2000-02-24 2006-04-11 Advancis Pharmaceutical Corp. Multiple-delayed released antibiotic product, use and formulation thereof
US6924253B2 (en) * 2000-04-07 2005-08-02 Bentley J. Palmer Scale removal
US6761895B2 (en) * 2000-04-17 2004-07-13 Yamanouchi Pharmaceutical Co., Ltd. Drug delivery system for averting pharmacokinetic drug interaction and method thereof
US6955821B2 (en) 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7838032B2 (en) 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US8012504B2 (en) 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7985420B2 (en) 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
AU2001279284A1 (en) * 2000-07-05 2002-01-14 Capricorn Pharma, Inc Rapid-melt semi-solid compositions, methods of making same and methods of using same
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US7157095B2 (en) 2000-10-13 2007-01-02 Advancis Pharmaceutical Corporation Multiple-delayed release antifungal product, use and formulation thereof
US7105174B2 (en) * 2000-10-13 2006-09-12 Advancis Pharmaceutical Corporation Multiple-delayed release anti-neoplastic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
GB0031267D0 (en) * 2000-12-21 2001-01-31 Smithkline Beecham Plc Novel compositions
US20020197314A1 (en) 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
AU2002244295B2 (en) * 2001-03-13 2006-02-09 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms containing glucocorticosteroid
EP1497148B2 (de) * 2002-04-12 2011-10-05 Edscha Cabrio-Dachsysteme GmbH Verdeck für ein cabriolet-fahrzeug
US20040114368A1 (en) * 2002-12-13 2004-06-17 Shyu Shing Jy Light device having rotatable or movable view
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1648418A4 (de) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
EP1653925A1 (de) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robustes pellet
AU2004264356B2 (en) 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP5686494B2 (ja) * 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1663156A2 (de) * 2003-09-19 2006-06-07 Penwest Pharmaceuticals Company Chronotherapeutische dosierformen
KR100782918B1 (ko) * 2003-09-19 2007-12-07 펜웨스트 파머슈티칼즈 컴파니 지연 방출성 제형
EP1701705A4 (de) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp Verbesserte absorption von dosierformen mit modifizierter freisetzung
AP2006003704A0 (en) * 2004-01-06 2006-08-31 Panacea Biotec Ltd Controlled release pharmaceutical composition comprising an acid insoluble polymer and a bioadhesivepolymer
WO2005099672A1 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
FR2872044B1 (fr) * 2004-06-28 2007-06-29 Flamel Technologies Sa Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
DE06769529T1 (de) 2006-01-27 2009-04-16 Schlumberger Holdings Ltd. Verfahren zur hydraulischen spaltenbildung einer unterirdischen formation
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US9120963B2 (en) * 2006-11-08 2015-09-01 Schlumberger Technology Corporation Delayed water-swelling materials and methods of use
WO2009063916A1 (ja) * 2007-11-16 2009-05-22 Asahi Kasei Chemicals Corporation 水系フィルムコーティング液、および、フィルムコーティング顆粒、ならびに、これを用いた錠剤
JP5101324B2 (ja) * 2008-02-07 2012-12-19 日立建機株式会社 建設機械のＮＯｘ低減装置の配設構造
US8839865B2 (en) * 2008-02-27 2014-09-23 Schlumberger Technology Corporation Slip-layer fluid placement
US9097077B2 (en) * 2009-10-30 2015-08-04 Schlumberger Technology Corporation Downhole chemical delivery system and method
US8459353B2 (en) 2010-08-25 2013-06-11 Schlumberger Technology Corporation Delivery of particulate material below ground
US9234415B2 (en) 2010-08-25 2016-01-12 Schlumberger Technology Corporation Delivery of particulate material below ground
US8714248B2 (en) 2010-08-25 2014-05-06 Schlumberger Technology Corporation Method of gravel packing
US8448706B2 (en) 2010-08-25 2013-05-28 Schlumberger Technology Corporation Delivery of particulate material below ground
EP3007568A4 (de) 2013-06-13 2016-11-09 Griffith Laboratories Verwendung resistenter stärken in beschichtungszusammensetzungen
WO2017062997A1 (en) 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation
JP2019527214A (ja) 2016-07-14 2019-09-26 アカオジェン インコーポレイテッド 細菌感染症の処置における使用のためのセフチブテンとクラブラン酸の組み合わせ
WO2022181625A1 (en) * 2021-02-23 2022-09-01 Otsuka Pharmaceutical Co., Ltd. Centanafadine pharmaceutical formulations, and methods of making and using same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US5679789A (en) * 1987-01-29 1997-10-21 Beecham Group, P.L.C. Pharmaceutical compositions comprising potassium clavulanate and methods of using them
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
US5827537A (en) * 1995-05-04 1998-10-27 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
PL334976A1 (en) * 1997-02-14 2000-03-27 Smithkline Beecham Lab Pharmaceutic preparations containing amoxycyclin and clavulate

Also Published As

Publication number Publication date
US5910322A (en) 1999-06-08
EP0776206A1 (de) 1997-06-04
ATE200981T1 (de) 2001-05-15
WO1996004908A1 (en) 1996-02-22
JPH10504818A (ja) 1998-05-12
GB9416600D0 (en) 1994-10-12
DE69520882T2 (de) 2002-01-10
EP0776206B1 (de) 2001-05-09
US6299903B1 (en) 2001-10-09

Similar Documents

Publication Publication Date Title
DE69520882D1 (de) Arzneizubereitung enthaltend amoxycillin und kaliumclavunalat
MY115351A (en) Pharmaceutical formulations
DE69532415D1 (de) Schmelzextrudierte oral verabreichbare opioidformulierungen
NO993887L (no) Farmasöytiske formuleringer som innbefatter amoksycillin og clavulanat
AU4882597A (en) Pharmaceutical preparations for the controlled release of beta-lactam antibiotics
DK0841903T3 (da) Orale farmaceutiske præparater indeholdende antimikrobielt virksomme aktivstoffer og sustained release pantoprazol
NO20025089D0 (no) Farmasöytiske preparater
IL141762A0 (en) New oral formulations
AU7052798A (en) Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
AU7052698A (en) Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
FI944035A (fi) Tramadolisuolaa sisältävä lääkeaine, jolla on viivästynyt vaikuttavan aineen vapautuminen
MY128809A (en) Pharmaceutical formulation of omeprazole
HUP9901437A3 (en) Pharmaceutical formulation, containing amoxycillin and clavulanate
WO2000061116A3 (en) Pharmaceutical formulation comprising amoxycillin and clavulanate
CY1107909T1 (el) Πολυστρωματικο δισκιο περιεχον ροσιγλιταζονη
ATE287264T1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
NL193820B (nl) Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
MA26788A1 (fr) COMPOSITIONS PHARMACEUTIQUES DESTINÉES à L'ADMINISTRATION PAR VOIE ORALE DE PHLOROGLUCINOL ET LEUR PRÉPARATION
DE69318153D1 (de) Antihypercholesterämisch-wirksame verbindungen, pharmazeutische präparate und verwendungen davon
ATA172297A (de) Pharmazeutische orale zusammensetzung enthaltend fk506
AU1880599A (en) Pharmaceutical composition for oral administration
JO1821B1 (en) New pharmaceutical product
TH22936B (th) สารผสมตามสูตรทางเภสัชกรรม

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee